The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Niece went to Boardmasters in Newquay last weekend. Everyone tested before entry with tests picking up just over 400 positive cases. Now I see on the news today that 5000 Covid cases have been linked to the event so far!!!
You get what you pay for. The industry and world is crying out for an accurate test.
If you missed Myles’s Avacta thesis from earlier in the week pop the kettle on and then read it twice over.
hTTps://aimchaos.com/2021/08/18/avacta-group-summary-of-revised-investment-thesis-18-08-2021/
Here’s a few questions to think about over the weekend.
If/when Avacta ramp up to full capacity using Medusa, Abingdon & the third manufacturers in Europe which is anticipated by year end, they’ll be producing over 700m tests a year.
Let’s think about that. €1-2 profit per test (Myles mentioned a conservative English £1) that’s 700m profit pa just from LFT’s. Doesn’t include the millions coming in from licensing fees etc.
We then move on from the sideshow to the real reason everyone is here and that is the utterly disruptive AVA6000. If the trials go to plan this will be truly massive news to the cancer world. The big players will want to get there hands on the ip during the first half of next year (after phase 1 at the end of March).
Just with the above we’ll have a company that has turned from making a loss to a profit of 700m pa just from LFT’s and ip that is worth many £billions.
Hold for the Sept update, hold for news on home use and scale up to full capacity, hold for AVA6000 leaks/news and then most importantly hold for the inevitable buy out.
All of the above will play out within the next 6/12 months.
Is it worth holding for £25 or more per share? You bet it is and it’s a very real possibility.
Avacta was a screaming buy at £2.90 a couple of months ago. The share price has dropped for no reason and if the Medusa news is confirmed we’ll be well on our way to £5+ in a very short space of time. Not only that but AVA6000 news will start to leak from as early as next week and more and more so as the trial continues. Positive leaks on this will see the share price soar past £10 with such disruptive technology. Avacta will within 12 months be bought by a major for £25 or more, I’m certain of it. Cancer is a multi £billion industry which will grow significantly with Avacta’s pro drugs. Good weekend all, we’re in for a great ride over the next few days, weeks and months. Full update towards the end of September too.